Auspex granted Teva rights to its deuterium-containing drug for further development

Auspex Pharmaceuticals Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Teva Pharmaceutical Industries Ltd.

Israel / Mid-Cap Biopharma ($1-$50 billion)

$48,793.7m on 12/31/2010 [market cap]

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced